◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

CKD Corporation (6407) EPS 2022–2026

Name: CKD Corporation (6407) eps history 2022-2026
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

DATA UPDATED 2026-08-11

CKD Corporation annual earnings per share (EPS) for fiscal 2026 was JPY 203.23, an increase of 0.4% from JPY 202.48 in fiscal 2025. All figures are reported results from public filings — no estimates or projections.

6407 Annual EPS

EPS (annual)	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Diluted EPS	JPY 203M	JPY 202M	JPY 125M	JPY 222M	—

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

6407 Quarterly EPS

EPS (quarterly)	2025-06-30
Diluted EPS	JPY 37M

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EPS at Comparable Companies

5631 EPS — The Japan Steel Works, Ltd.
6141 EPS — DMG Mori Co., Ltd.
6508 EPS — Meidensha Corporation
6728 EPS — ULVAC, Inc.
6507 EPS — Sinfonia Technology Co.,Ltd.
6005 EPS — Miura Co., Ltd.

More 6407 metrics: Revenue · Gross Profit · Operating Income · Net Income · Free Cash Flow

All 6407 financial statements → Interactive 6407 charts →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.